Get the app today! App Store Play Store

J&J Shares Fall Due to 'Disappointing' Product Sales

Published on Apr 20 2017 11:41 AM in A-Brands tagged: Johnson & Johnson / Janssen Biologics / Janssen Pharmaceuticals / DePuy Synthes / Vistakon

J&J Shares Fall Due to 'Disappointing' Product Sales

Johnson & Johnson reported a fall in its shares due to 'disappointing' pharmaceutical and consumer product sales.

Its shares fell over 3.5% at one stage in the biggest one-day percentage decline in more than eight years, reported

Overall sales of $17.77 billion (€16.7 billion) in the quarter fell short of analysts’ average estimate of over $18billion.

The multinational medical devices, pharmaceutical and consumer manufacturer employs 2,200 people at its Irish sales facilities and plants which include Janssen Biologics, Janssen Pharmaceuticals, and DePuy Synthes in Cork, and Vistakon in Limerick.

© 2017 - Checkout Magazine by Donna Ahern

Share on Facebook Share on Twitter Share on LinkedIn Share via Email